Cargando…
Changing clinical manifestations of Gaucher disease in Taiwan
BACKGROUND: Gaucher disease (GD) is a lysosomal storage disorder characterized by deficient glucocerebrosidase activity that results from biallelic mutations in the GBA1 gene. Its phenotypic variability allows GD to be classified into 3 subtypes based on the presence and extent of neurological manif...
Autores principales: | Lu, Wen-Li, Chien, Yin-Hsiu, Tsai, Fuu-Jen, Hwu, Wuh-Liang, Chou, Yen-Yin, Chu, Shao-Yin, Li, Meng-Ju, Lee, An-Ju, Liao, Chao-Chuan, Wang, Chung-Hsing, Lee, Ni-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502973/ https://www.ncbi.nlm.nih.gov/pubmed/37715271 http://dx.doi.org/10.1186/s13023-023-02895-z |
Ejemplares similares
-
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
por: Lee, Ni-Chung, et al.
Publicado: (2022) -
Curated incidence of lysosomal storage diseases from the Taiwan Biobank
por: Tsai, Meng-Ju Melody, et al.
Publicado: (2023) -
The Timely Needs for Infantile Onset Pompe Disease Newborn Screening—Practice in Taiwan
por: Chiang, Shu-Chuan, et al.
Publicado: (2020) -
Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: Evidence from real-world experiences
por: Chien, Yin-Hsiu, et al.
Publicado: (2020) -
Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study
por: Peng, Steven Shinn-Forng, et al.
Publicado: (2016)